Redmile Group
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
- United States
Investment stages
- Seed
- Series A
- Series B
- Series C
- Growth
Industries
- Life Sciences
- Biotechnology
- Health Tech
About
Redmile Group is a global investment firm specializing in healthcare, investing across public and private markets to support companies driving advancements in biotechnology, therapeutics, and healthcare delivery.
Redmile Group is a global investment firm specializing in healthcare, investing across public and private markets to support companies driving advancements in biotechnology, therapeutics, and healthcare delivery.
Investment Thesis
Redmile Group is a San Francisco–based healthcare investment firm specializing in early-stage, venture, private equity, and post-IPO equity investments focused on biotechnology, therapeutics, life sciences, and medical devices. Its strategy centers on identifying companies with significant growth potential in innovative R&D, frequently leading investment rounds with sizable capital deployments.
Manager's Experience
Redmile Group is a healthcare-dedicated investment firm with senior leaders drawn from long biotech and pharma careers, though specific tenure details and team backgrounds are not openly outlined on their site.